Peak Financial Advisors LLC Invests $1.02 Million in CVS Health Corporation $CVS

Peak Financial Advisors LLC acquired a new position in shares of CVS Health Corporation (NYSE:CVS) in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 14,809 shares of the pharmacy operator’s stock, valued at approximately $1,022,000.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Roxbury Financial LLC boosted its position in shares of CVS Health by 78.3% during the 2nd quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock worth $32,000 after acquiring an additional 202 shares in the last quarter. Thurston Springer Miller Herd & Titak Inc. boosted its position in shares of CVS Health by 11.0% during the 2nd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 12,053 shares of the pharmacy operator’s stock worth $832,000 after acquiring an additional 1,195 shares in the last quarter. Central Pacific Bank Trust Division boosted its position in shares of CVS Health by 1.5% during the 2nd quarter. Central Pacific Bank Trust Division now owns 33,000 shares of the pharmacy operator’s stock worth $2,276,000 after acquiring an additional 500 shares in the last quarter. Kera Capital Partners Inc. acquired a new position in shares of CVS Health during the 2nd quarter worth about $371,000. Finally, AG2R LA Mondiale Gestion D Actifs acquired a new position in shares of CVS Health during the 1st quarter worth about $2,989,000. 80.66% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of brokerages recently issued reports on CVS. Baird R W raised CVS Health from a “hold” rating to a “strong-buy” rating in a research report on Thursday, August 14th. Cowen reissued a “buy” rating on shares of CVS Health in a research report on Monday, August 4th. Wall Street Zen cut CVS Health from a “buy” rating to a “hold” rating in a research report on Saturday. Jefferies Financial Group upped their target price on CVS Health from $74.00 to $80.00 and gave the company a “buy” rating in a research report on Monday, June 30th. Finally, Zacks Research cut CVS Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 8th. Two research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, CVS Health has a consensus rating of “Moderate Buy” and an average target price of $77.89.

CVS Health Stock Performance

NYSE CVS opened at $75.00 on Friday. CVS Health Corporation has a 1-year low of $43.56 and a 1-year high of $75.55. The company has a market capitalization of $95.12 billion, a P/E ratio of 20.95, a PEG ratio of 0.82 and a beta of 0.62. The business has a 50 day moving average price of $67.11 and a 200 day moving average price of $66.32. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.80 and a quick ratio of 0.62.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.46 by $0.35. CVS Health had a return on equity of 10.51% and a net margin of 1.17%.The firm had revenue of $98.92 billion during the quarter, compared to the consensus estimate of $94.87 billion. During the same period last year, the business posted $1.83 EPS. CVS Health’s quarterly revenue was up 8.4% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. Sell-side analysts expect that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, August 1st. Shareholders of record on Tuesday, July 22nd were issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 3.5%. The ex-dividend date was Tuesday, July 22nd. CVS Health’s dividend payout ratio is 74.30%.

Insider Buying and Selling

In other CVS Health news, Director Anne A. Finucane sold 7,500 shares of the stock in a transaction on Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total transaction of $532,650.00. Following the sale, the director owned 22,156 shares in the company, valued at approximately $1,573,519.12. This represents a 25.29% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 1.22% of the company’s stock.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.